Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1984 1
1988 1
1991 1
1992 3
1993 1
1994 5
1995 4
1996 10
1997 9
1998 15
1999 15
2000 16
2001 18
2002 17
2003 31
2004 20
2005 16
2006 18
2007 20
2008 20
2009 13
2010 6
2011 18
2012 12
2013 21
2014 14
2015 23
2016 11
2017 25
2018 12
2019 8
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

398 results
Results by year
Filters applied: . Clear all
Page 1
Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells.
Zhou L, Huntington K, Zhang S, Carlsen L, So EY, Parker C, Sahin I, Safran H, Kamle S, Lee CM, Lee CG, Elias JA, Campbell KS, Naik MT, Atwood WJ, Youssef E, Pachter JA, Navaraj A, Seyhan AA, Liang O, El-Deiry WS. Zhou L, et al. Among authors: el deiry ws. bioRxiv. 2020 Aug 3:2020.08.02.230839. doi: 10.1101/2020.08.02.230839. Preprint. bioRxiv. 2020. PMID: 32793908 Free PMC article.
AMG-232 sensitizes high MDM2-expressing tumor cells to T-cell-mediated killing.
Sahin I, Zhang S, Navaraj A, Zhou L, Dizon D, Safran H, El-Deiry WS. Sahin I, et al. Among authors: el deiry ws. Cell Death Discov. 2020 Jul 6;6:57. doi: 10.1038/s41420-020-0292-1. eCollection 2020. Cell Death Discov. 2020. PMID: 32655895 Free PMC article.
Molecular profile of BRCA-mutated biliary tract cancers.
Spizzo G, Puccini A, Xiu J, Goldberg RM, Grothey A, Shields AF, Arora SP, Khushmann M, Salem ME, Battaglin F, Baca Y, El-Deiry WS, Philip PA, Nassem M, Hall M, Marshall JL, Kocher F, Amann A, Wolf D, Korn WM, Lenz H, Seeber A. Spizzo G, et al. Among authors: el deiry ws. ESMO Open. 2020 Jun;5(3):e000682. doi: 10.1136/esmoopen-2020-000682. ESMO Open. 2020. PMID: 32576609 Free PMC article.
Quassinoid analogs with enhanced efficacy for treatment of hematologic malignancies target the PI3Kγ isoform.
Pei Y, Hwang N, Lang F, Zhou L, Wong JH, Singh RK, Jha HC, El-Deiry WS, Du Y, Robertson ES. Pei Y, et al. Among authors: el deiry ws. Commun Biol. 2020 May 27;3(1):267. doi: 10.1038/s42003-020-0996-z. Commun Biol. 2020. PMID: 32461675 Free PMC article.
Targeting apoptosis in cancer therapy.
Carneiro BA, El-Deiry WS. Carneiro BA, et al. Among authors: el deiry ws. Nat Rev Clin Oncol. 2020 Jul;17(7):395-417. doi: 10.1038/s41571-020-0341-y. Epub 2020 Mar 23. Nat Rev Clin Oncol. 2020. PMID: 32203277 Review.
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.
Harrington CT, Sotillo E, Robert A, Hayer KE, Bogusz AM, Psathas J, Yu D, Taylor D, Dang CV, Klein PS, Hogarty MD, Geoerger B, El-Deiry WS, Wiels J, Thomas-Tikhonenko A. Harrington CT, et al. Among authors: el deiry ws. Leukemia. 2020 May;34(5):1485. doi: 10.1038/s41375-019-0650-2. Leukemia. 2020. PMID: 31758088
Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
Winer A, Ghatalia P, Bubes N, Anari F, Varshavsky A, Kasireddy V, Liu Y, El-Deiry WS. Winer A, et al. Among authors: el deiry ws. Oncologist. 2019 Nov;24(11):1416-1419. doi: 10.1634/theoncologist.2018-0686. Epub 2019 Aug 23. Oncologist. 2019. PMID: 31444293 Free PMC article.
Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient.
Regan S, Yang X, Finnberg NK, El-Deiry WS, Pu JJ. Regan S, et al. Among authors: el deiry ws. Cancer Biol Ther. 2019;20(11):1389-1397. doi: 10.1080/15384047.2019.1647055. Epub 2019 Aug 18. Cancer Biol Ther. 2019. PMID: 31423878
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration.
Stein MN, Malhotra J, Tarapore RS, Malhotra U, Silk AW, Chan N, Rodriguez L, Aisner J, Aiken RD, Mayer T, Haffty BG, Newman JH, Aspromonte SM, Bommareddy PK, Estupinian R, Chesson CB, Sadimin ET, Li S, Medina DJ, Saunders T, Frankel M, Kareddula A, Damare S, Wesolowsky E, Gabel C, El-Deiry WS, Prabhu VV, Allen JE, Stogniew M, Oster W, Bertino JR, Libutti SK, Mehnert JM, Zloza A. Stein MN, et al. Among authors: el deiry ws. J Immunother Cancer. 2019 May 22;7(1):136. doi: 10.1186/s40425-019-0599-8. J Immunother Cancer. 2019. PMID: 31118108 Free PMC article. Clinical Trial.
The current state of molecular testing in the treatment of patients with solid tumors, 2019.
El-Deiry WS, Goldberg RM, Lenz HJ, Shields AF, Gibney GT, Tan AR, Brown J, Eisenberg B, Heath EI, Phuphanich S, Kim E, Brenner AJ, Marshall JL. El-Deiry WS, et al. CA Cancer J Clin. 2019 Jul;69(4):305-343. doi: 10.3322/caac.21560. Epub 2019 May 22. CA Cancer J Clin. 2019. PMID: 31116423 Free PMC article. Review.
398 results
Jump to page
Feedback